Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...
Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corp...
Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, I...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...
Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compoun...
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...
Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a ne...
Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...
Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...
The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...
